effect of magnesium sulphate and dexmedetomidine on cerebral oxygenation in shoulder surgery

Cerebral oxygenation during hypotensive anesthesia in shoulder arthroscopy: comparative study between magnesium sulphate and dexmedetomidine

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202006485196275

Enrollment

100

Registered

2020-06-24

Start date

2020-06-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedics Anaesthesia

Interventions

magnesium sulphate

dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients aged 20-60 years, both sex, elective arthroscopic shoulder surgery in the beach chair position will be enrolled in the study

Exclusion criteria

Exclusion criteria: patient's refusal, pre-existing cerebrovascular or psychiatric disorders, carotid stenosis, cervical stenosis or cervical disc herniation, myocardial infarction, spinal cord injury, a history of stroke, transient ischemic attack, orthostatic hypotension or syncope, or neck surgery.

Design outcomes

Primary

Measure	Time frame
frequency of cerebral oxygen desaturation.	—

Secondary

Measure	Time frame
Cognitive dysfunction is evaluated by mini mental state examination (MMSE). ;haemodynamic parameters which is heart rate and mean arterial blood pressure;surgeon satisfaction;Complications (e.g. nausea, vomiting, hypotension when MBP <65 mmHg, bradycardia when HR<50 beat/min).	—

Countries

Egypt

Contacts

Public ContactMona Elghamry

lecturer

drmonagh19802000@gmail.com+201060101867

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026